Abstract:Importance: Median organ waiting times published by transplant organizations may be biased when not appropriately accounting for censoring, death, and competing events. This can lead to overly optimistic waiting times for all transplant programs and, consequently, may deceive patients on the waiting list, transplant physicians, and health care policymakers. Objective: To apply competing-risk multistate models to calculate probabilities for transplantation and adverse outcomes on the Swiss national transplant waiting list. Design, setting, and participants: The WAIT (Waitlist Analysis in Transplantation) study was a retrospective cohort study of all transplant candidates in Switzerland listed from January 1, 2018, or later and observed until December 31, 2023. Transplant candidates were listed in 1 of the 6 transplant centers (Basel, Bern, Geneva, Lausanne, St Gallen, and Zurich) for heart, liver, lungs, kidney, or pancreas and/or islet transplant. A total of 4352 candidates were listed during the study period, of whom 709 (16.3%) were excluded due to living-donor transplant (691 in the kidney program and 18 in the liver program). Exposure: Waiting for organ transplant. Main outcomes and measures: Time to transplantation, death, or delisting. Competing-risk multistate models were used to analyze time-to-event data from the national organ waiting list with the Aalen-Johansen estimator to compute probabilities for both transplant and adverse outcomes. Results were compared with the sample median among only those undergoing transplant and the Kaplan-Meier method with censoring of competing events. Results: Data from 3643 transplant candidates (2428 [66.6%] male; median age, 56 [range, 0-79] years) were included in the analysis. The median time to transplantation (MTT) was 0.91 (95% CI, 0.83-1.07) years for heart, 3.10 (95% CI, 2.57-3.77) years for kidney, 1.32 (95% CI, 0.76-1.55) years for liver, 0.80 (95% CI, 0.37-1.12) years for lung, and 1.62 (95% CI, 0.91-2.17) years for pancreas and/or islet programs. Alternative estimation methods introduced bias to varying degrees: the sample median among only persons undergoing transplantation underestimated the waiting time by 38% to 61% and the Kaplan-Meier method by 2% to 12% compared with the MTT. Conclusions and relevance: In this cohort study of transplant candidates in Switzerland, the MTT, the duration at which the transplant probability is 0.50, was used as a measure of average waiting time. Suboptimal methods led to biased and overly optimistic waiting time estimations; thus, applying appropriate competing-risk methods to address censoring and competing events is crucial.

Estimated Median Waiting Time for Organ Procurement and Transplantation Network Human Immunodeficiency Virus Organ Policy Equity Act Variance Kidney Candidates: A Propensity Score Matched Analysis

Longitudinal analysis of viral dynamics in HIV+-to-HIV+ HOPE Act kidney-transplant recipients

Renal Transplantation in HIV-positive and HIV-negative Patients with Advanced Stages of Kidney Disease: Equity in Transplantation

Beyond Immunity: Challenges in Kidney Retransplantation Among Persons Living With HIV

Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment

Policies and practice of solid organ donation amongst people living with HIV in Canada: time for education and re-evaluation

Impact of OPTN policy 3.7D providing waiting time modification for candidates affected by race‐inclusive eGFR calculations: Early results from a single center

Impact of race‐neutral eGFR calculations on African American kidney transplant candidate wait time: A single center retrospective analysis

Determinants of Long Waiting Time to Kidney Transplantation

Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality

HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants

Selection Bias in Reporting of Median Waiting Times in Organ Transplantation

Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States

Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group

Quantifying the Effect of Consent for High–Kidney Donor Profile Index Deceased Donor Transplants in the United States

The impact of multi‐organ transplant allocation priority on waitlisted kidney transplant candidates

Risk and Reward: Nationwide Analysis of Cardiac Transplant Center Variation in Organ Travel Distance and the Effects on Outcomes

Lung transplantation in HIV seropositive recipients: An analysis of the UNOS registry

The impact of the OPTN policy change on patients with a durable left ventricular assist device and chronic kidney disease: Analysis of the UNOS database

Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm